ASTON, Pennsylvania, February 10, 2021 – InfuCare Rx, a leading nationwide specialty infusion provider in the treatment of acute and chronic conditions, announced this week their selection as a preferred provider in Cigna’s eviCore healthcare specialty pharmacy network. InfuCare Rx has been selected as a preferred provider based on its high quality clinical therapy management capabilities, national scope and real-time data driven outcomes reporting through its proprietary digital solution, InfuCare Rx Health. InfuCare Rx will provide a variety of specialty and non-specialty infusion services to Cigna members through eviCore healthcare. These services will include anti-infective therapy, bleeding disorders, immunoglobulin therapy (IV and subcutaneous), parenteral nutrition and specialty biologics effective February 1, 2021.